A quiet week, and the most useful thing in it is something that did not happen: with eleven days to go until the date everyone has pencilled in for the Tobacco and Vapes Act 2026, there are still no commencement regulations for England and Wales. Beyond that, no pouch authorisation, no enforcement action, no new instrument anywhere in the EU, no litigation and no new science. Three sets of quarterly results land in the next fortnight and they are where the substance will be.
The week in one table
| Beat | Change 12–18 October | Where it stands now |
|---|---|---|
| FDA authorisations | None | 43 products, two companies, page unchanged since 21 August 2026 |
| FDA enforcement | None issued; one earlier letter posted 13 Oct | Last CTP warning letters issued 25 September and 2 October |
| FDA committees | Four new TPSAC members named, nominations opened 14 Oct | Covered separately on 16 October |
| UK | No instrument laid | Still no England and Wales commencement regulations |
| EU | No new notification | Latest pouch-related standstill ended 2 October |
| Litigation | No filing, entry or decision | Dockets quiet across the window |
| Corporate | One BAT share-dealing disclosure | PMI 21 Oct, Altria and JT 29 Oct |
| Science | No new pouch paper | Six papers published in the window, none about pouches |
Britain’s tobacco act still has no start date for England
This is the item worth your attention, and it is a negative.
The complete set of secondary legislation made under the Tobacco and Vapes Act 2026 currently runs to four instruments: an England regulation on age-of-sale notices, two Scottish instruments, and one Northern Ireland commencement order. That is the whole list. There are no commencement regulations for England and Wales at all.
The one England instrument that exists, the Age of Sale Notices and Consequential Amendments Regulations 2026, was made on 7 September 2026 and comes into force on 1 January 2027. It does not commence the Act; it deals with the notices retailers must display.
So the 29 October 2026 date in wide circulation is not, and has never been, a date anyone laid before Parliament. It is a date derived from the commencement formula in section 175(1) of the Act itself. That is a legitimate reading, but it is a calculation rather than a quoted instrument, and until regulations appear it should be described that way. We have been careful about this on our own pages and will keep checking the register weekly. Nothing was laid this week.
FDA: the advisory committee, and nothing else
The only US federal tobacco action in the window was FDA announcing four new voting members of the Tobacco Products Scientific Advisory Committee and opening nominations for two more, with a closing date of 14 December 2026. We covered that in full on 16 October, so it is a cross-reference here rather than a story.
Everything else on the federal beat was still. The authorised-pouch list has not moved since 21 August: 43 products, from Helix Innovations and Swedish Match USA, and nothing added. FDA’s marketing-orders page shows the most recent decision of any kind as 28 August, for JUUL. The Center for Tobacco Products issued no warning letters in the window — the only pouch-adjacent letter to surface was one posted on 13 October but issued on 2 October, and it concerns an online e-liquid retailer, with pouches appearing only in FDA’s standard jurisdictional recital that its authority covers “cigarettes, smokeless tobacco, cigars, e-cigarettes, and nicotine pouches”. That is boilerplate, not an enforcement trend.
Europe: the eight-minister push produced no paperwork
Nothing new followed the move by eight member states toward national pouch bans that we reported last week.
The place a national measure would show up first is the Commission’s technical-regulation notification system, because a member state must notify a draft and then wait out a standstill period. Searching 2026 notifications for nicotine, pouches, tobacco and snus turns up a handful, and not one has a reception date or a standstill end-date inside this week. The most recent of substance is the Dutch notification on nicotine limits in tobacco-free products, received on 1 July, whose standstill ended on 2 October. Luxembourg’s labelling notification ended in April; Poland’s in August; two Finnish ones in July.
At national level the newsrooms were empty: Sweden’s public health agency and government press pages, Norway’s health directorate, the Dutch government, Germany’s BfR and health ministry, and Poland’s health ministry all published nothing on nicotine in the window. Several other countries’ official sites could not be reached from here at all, which is a limit on the sweep rather than a finding, and it is named below.
Courts and companies
No filing, docket entry or decision involving nicotine pouches appears in the public federal court records for the window. That is a real search rather than an assumption — the same query without the date filter returns fifty live matters — but it covers what is indexed, so read it as “nothing surfaced” rather than “nothing exists”.
One widely-shared item needs correcting because it keeps being dated to October: the Texas Supreme Court decision on whether VELO is taxable is from 8 May 2026, not this month. The court’s 16 October order list contains nothing on tobacco or nicotine.
On the corporate side, Philip Morris International filed nothing at all with the SEC in the first eighteen days of October. Altria’s only in-window filing is an insider share-dealing form on 16 October; its 8-K was on 9 October, before the window. BAT filed five documents in October, of which the only one inside the window — 15 October — is a managerial share-dealing notification with no business content. Turning Point Brands filed nothing. Haypp Group’s most recent press release remains 3 September.
The quarter lands next. PMI reports on 21 October, which is where the first Q3 shipment figure for ZYN will appear; Altria and Japan Tobacco both report on 29 October. If you only read one roundup this month for the numbers, read next week’s.
Science: six papers, none of them about pouches
Six papers carry a publication date inside the window. Three mention pouches, none studies them.
A Texas survey of 17,750 college students treats pouch use as a covariate in a study of heated-tobacco awareness, reporting that “Former and current (vs. never) smoking, smokeless tobacco, and nicotine pouch use were positively associated with awareness and use”. A BMJ Public Health paper folds pouches into a composite outcome alongside e-cigarettes. A spine paper mentions them in its introduction and was in any case published online in November 2025 — the October date is the print issue. The remaining three concern cessation advice, a Norwegian pregnancy cohort using snus, and the 2025 youth risk behaviour survey.
That last one is quietly interesting: the 2025 YRBS measures do not include nicotine pouches at all. The main instrument for tracking US adolescent risk behaviour is not counting the product category everyone is arguing about.
Circulated without a primary source
Several items moved through the trade press this week that we are not reporting, because we could not reach the document behind them. Naming what is missing is more useful than repeating the claim.
- Haypp on social media driving pouch discovery in the UK. Missing: Haypp Group’s own report or release. Its press pages return errors and its newest item anywhere is 3 September.
- JTI expanding its oral nicotine range with a new brand. Missing: a JTI release. Every jti.com newsroom path rate-limited us across repeated attempts.
- A PMI study on EU economic contribution. Missing: the study itself. PMI’s press-release detail pages return the same template whatever the release ID. Tangential to pouches in any case.
- Italy raising prices on selected tobacco products. Missing: the customs agency determination or the tariff table. We could not establish whether pouches are even in scope.
- The Philippines mandating safety certification for pouches. Missing: the department administrative order text. The listing page is blocked, and the story appears to be dated 8 October or earlier, so probably outside this week regardless.
What to watch
- 21 October: PMI Q3 results, and the quarter’s ZYN shipment volumes.
- 29 October: Altria and Japan Tobacco Q3. Also the derived commencement date for the Tobacco and Vapes Act 2026 in England and Wales — watch for regulations before then, or for the date to pass without them.
- 14 December: TPSAC nominations close.
- Ongoing: whether any of the eight EU member states notifies a draft national measure. The notification register is the early-warning system, and it was empty this week.
How this was put together, and what it does not cover
Every item above was checked against a primary document — FDA’s own pages, the UK legislation register, the Commission’s notification database, SEC filings, the federal court index and PubMed. Stories we could not trace to a document are listed as such rather than reported.
Two limits worth stating. We did not enumerate all fifty US state attorneys-general and revenue departments, so the US state negative rests on court and press searching rather than an exhaustive sweep. And official sites in Denmark, France, Czechia, Belgium, Ireland, Italy, Spain and Finland could not be reached from here this week, so for those countries the European negative rests on the EU-level notification register alone, which covers draft technical regulations but not enforcement or consultations.
Sources
- legislation.gov.uk — the complete instrument list for the Tobacco and Vapes Act 2026, and SI 2026/996, made 7 September 2026, in force 1 January 2027.
- FDA, TPSAC nominations and new members, 14 October 2026.
- FDA, Nicotine Pouch Products Authorized by the FDA (content current as of 21 August 2026) and Tobacco Products Marketing Orders.
- FDA, warning letter issued 2 October 2026, posted 13 October.
- European Commission, technical regulation notification system — 2026 notifications searched for nicotine, pouch, tobacco and snus.
- SEC EDGAR submissions for Philip Morris International, Altria and British American Tobacco.
- Supreme Court of Texas, orders of 16 October 2026.
- PubMed, publication dates 12–18 October 2026, searched via the NCBI E-utilities.
